Aggressive BehaviorNCT07311174
Can Psychodrama Improve Aggressive Behavior and Social Adaptation in Adolescent Boys?
A study testing Psychodrama in people with Aggressive Behavior, run by Kerman University of Medical Sciences at 1 site in Iran.
Trial summary
This randomized controlled trial evaluated the effectiveness of a 10-session psychodrama intervention on reducing aggressive behavior and improving social adjustment among male adolescents with high aggression and low social adjustment in Bandar Abbas, southern Iran. Read more about this study
- Who is it for?
- Any age, men only
- Conditions the study is for
- Aggressive Behavior
- What is being tested?
- Psychodrama
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 22 participants
- Where
- 1 siteIran
- Study dates
- 5 Mar 2023to 29 Jul 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Men only
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- Male, 7th or 8th-grade student (aged 11-13).
- BPAQ score > 117.
- BAI score between 16 and 20.
- Able to commute to after-school classes.
- Parental informed consent obtained.
Who cannot join
- Physical disability or severe illness.
- History of major psychiatric disorders or current psychiatric medication use.
- Unwillingness to participate or missing >2 sessions.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Can Psychodrama Improve Aggressive Behavior and Social Adjustment? A Randomized Controlled Trial Among Male Adolescents in a Tropical Developing Region
This randomized controlled trial evaluated the effectiveness of a 10-session psychodrama intervention on reducing aggressive behavior and improving social adjustment among male adolescents with high aggression and low social adjustment in Bandar Abbas, southern Iran. Twenty-two eligible students were randomly assigned to either a psychodrama intervention group or a comparison group. Outcomes were assessed using the Buss-Perry Aggression Questionnaire and the Bell Adjustment Inventory before and after the intervention.
Read the detailed description
This randomized controlled trial was conducted in 2023 among male adolescents aged 11-15 years at a public secondary school in Bandar Abbas, a tropical hot desert region in southern Iran. Students were screened using the Buss-Perry Aggression Questionnaire (BPAQ) and the Bell Adjustment Inventory (BAI). Those with high aggression (BPAQ >117) and low social adjustment (BAI score 16-20) were eligible.
Twenty-two students meeting eligibility criteria were randomly assigned in a 1:1 ratio to either the psychodrama intervention group (n=11) or the comparison group (n=11). One participant in the intervention group dropped out, resulting in final analysis of 21 participants.
The intervention consisted of 10 weekly 90-minute psychodrama sessions based on Blatner's protocol, including role-playing, mirroring, soliloquy, storytelling, future projection, and relaxation exercises. The comparison group received no intervention during the study period but was offered the program after study completion.
Primary outcomes were aggression (measured by BPAQ) and social adjustment (measured by BAI), assessed at baseline and post-intervention. Data were analyzed using ANCOVA and repeated measures ANOVA.
- Conditions
- Aggressive Behavior
- Being tested
- Psychodrama, Control
- Medical subject headings
- Aggression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PsychodramaBehavioural
Participants received a 10-session structured psychodrama intervention based on Blatner's protocol. Sessions were held weekly for 90 minutes.
ControlOther
The control group recieved no intervention during 10 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Psychodrama | Experimental | Participants received a 10-session structured psychodrama intervention based on Blatner's protocol. Sessions were held weekly for 90 minutes. Receives: Behavioral: Psychodrama |
| Standard school program | Active comparator | Participants continued with their standard school educational program. They received no additional sessions, therapy, or intervention during the 10-week study period.
Other: Standard Care Receives: Other: Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Bell Adjustment Inventory
Higher scores= Worst outcome (Poorer adjustment).
Measured: Pre-intervention and immediately post-intervention (10 weeks)
Buss-Perry Aggression Questionnaire
Higher scores= Worst outcome (Greater aggression).
Measured: Pre-intervention and immediately post-intervention (10 weeks)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Dec 2025
- Study start5 Mar 2023
- Primary completion7 Jul 2023
- Study completion29 Jul 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Aggressive BehaviorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 22 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kerman University of Medical Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Parvin Rezaei-Gazki, Kerman University of Medical Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07311174
- Sponsor's protocol ID
- IR.IAU.BA.REC.1402.049
- Status last verified
- Jan 2026
- First submitted
- 16 Dec 2025
- Last updated
- 6 Jan 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 6 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Can Psychodrama Improve Aggressive Behavior and Social Adjustment? A Randomized Controlled Trial Among Male Adolescents in a Tropical Developing Region
- ClinicalTrials.gov ID
- NCT07311174
- Acronym / sponsor ID
- IR.IAU.BA.REC.1402.049
- Conditions
- Aggressive Behavior
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 22 participants (actual)
- Lead sponsor
- Kerman University of Medical SciencesUniversity, hospital or other
- Study start
- 5 Mar 2023 (actual)
- Primary completion
- 7 Jul 2023 (actual)
- Study completion
- 29 Jul 2023 (actual)
- First posted
- 30 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial evaluated the effectiveness of a 10-session psychodrama intervention on reducing aggressive behavior and improving social adjustment among male adolescents with high aggression and low social adjustment in Bandar Abbas, southern Iran. Twenty-two eligible students were randomly assigned to either a psychodrama intervention group or a comparison group. Outcomes were assessed using the Buss-Perry Aggression Questionnaire and the Bell Adjustment Inventory before and after the intervention.
Detailed description
This randomized controlled trial was conducted in 2023 among male adolescents aged 11-15 years at a public secondary school in Bandar Abbas, a tropical hot desert region in southern Iran. Students were screened using the Buss-Perry Aggression Questionnaire (BPAQ) and the Bell Adjustment Inventory (BAI). Those with high aggression (BPAQ >117) and low social adjustment (BAI score 16-20) were eligible.
Twenty-two students meeting eligibility criteria were randomly assigned in a 1:1 ratio to either the psychodrama intervention group (n=11) or the comparison group (n=11). One participant in the intervention group dropped out, resulting in final analysis of 21 participants.
The intervention consisted of 10 weekly 90-minute psychodrama sessions based on Blatner's protocol, including role-playing, mirroring, soliloquy, storytelling, future projection, and relaxation exercises. The comparison group received no intervention during the study period but was offered the program after study completion.
Primary outcomes were aggression (measured by BPAQ) and social adjustment (measured by BAI), assessed at baseline and post-intervention. Data were analyzed using ANCOVA and repeated measures ANOVA.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Psychodrama | Experimental | Behavioral: PsychodramaParticipants received a 10-session structured psychodrama intervention based on Blatner's protocol. Sessions were held weekly for 90 minutes. |
| Standard school program | Active comparator | Other: ControlParticipants continued with their standard school educational program. They received no additional sessions, therapy, or intervention during the 10-week study period. Other: Standard Care |
Who may qualify
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (5 listed)
- Male, 7th or 8th-grade student (aged 11-13).
- BPAQ score > 117.
- BAI score between 16 and 20.
- Able to commute to after-school classes.
- Parental informed consent obtained.
Key exclusion criteria (3 listed)
- Physical disability or severe illness.
- History of major psychiatric disorders or current psychiatric medication use.
- Unwillingness to participate or missing >2 sessions.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PsychodramaParticipants received a 10-session structured psychodrama intervention based on Blatner's protocol. Sessions were held weekly for 90 minutes. | Behavioural | Psychodrama |
| ControlThe control group recieved no intervention during 10 weeks. | Other | Standard school program |
Primary outcome
Bell Adjustment Inventory
Time frame: Pre-intervention and immediately post-intervention (10 weeks)
Higher scores= Worst outcome (Poorer adjustment).
Buss-Perry Aggression Questionnaire
Time frame: Pre-intervention and immediately post-intervention (10 weeks)
Higher scores= Worst outcome (Greater aggression).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jan 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Aggressive Behavior
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingPhase 3
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Metastatic Dedifferentiated Liposarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma
RecruitingPhase 2
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma
Recruiting
Momentary Coping Prompts and Hair Steroids in College Students
Emotional Regulation, Alcohol Drinking in College
Active, not recruitingPhase 1/2
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
DLBCL, High-grade B-cell Lymphoma (HGBCL)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Psychodrama in people with Aggressive Behavior, run by Kerman University of Medical Sciences at 1 site in Iran.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Bell Adjustment Inventory (time frame: Pre-intervention and immediately post-intervention (10 weeks)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2026.